Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company, today announced that it has received approval from the DCGI (Drug Controller General of India), the regulator in India to conduct clinical trials on Favipiravir Antiviral.
source https://www.pharmatutor.org/pharma-news/2020/glenmark-receives-dcgi-approval-for-favipiravir-trial-for-covid-19-patients
No comments:
Post a Comment